A detailed history of Acadian Asset Management LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 243,273 shares of NAUT stock, worth $442,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares
243,273
Previous 69,208 251.51%
Holding current value
$442,756
Previous $48,000 322.92%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$0.64 - $0.84 $111,401 - $146,214
174,065 Added 251.51%
243,273 $203,000
Q2 2025

Aug 07, 2025

BUY
$0.67 - $0.93 $5,006 - $6,949
7,473 Added 12.1%
69,208 $48,000
Q1 2025

May 21, 2025

BUY
$0.86 - $2.04 $43,749 - $103,776
50,871 Added 468.25%
61,735 $51,000
Q4 2024

Feb 11, 2025

BUY
$1.67 - $2.96 $18,142 - $32,157
10,864 New
10,864 $18,000
Q4 2022

Feb 14, 2023

BUY
$1.55 - $2.47 $60,091 - $95,759
38,769 New
38,769 $69,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $227M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.